Aryaman Capital Markets Limited (ARYACAPM.BO)
INR 214.0
(0.0%)
INR 214.0
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 88.09 Million | 53.18 Million | 75.29 Million | 104.37 Million | -64.74 Million | -226.16 Million |
| Net Income | 64.55 Million | 14.87 Million | 3.24 Million | 2.54 Million | 948 Thousand | 2.17 Million |
| Depreciation & Amortization | 850 Thousand | 734 Thousand | 453 Thousand | 562 Thousand | 622 Thousand | 891 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.14 Million | 36.32 Million | 70.58 Million | 97.83 Million | -65.33 Million | -228.12 Million |
| Other non-cash items | 19.54 Million | 4.34 Million | 4.43 Million | 363 Thousand | -189 Thousand | 198.15 Million |
| Investing Cash Flow | 18.75 Million | -21.58 Million | -18.63 Million | 10.95 Million | 47.92 Million | 90.5 Million |
| Investments in PPE | -1.17 Million | -1.99 Million | -46 Thousand | -66 Thousand | -1.74 Million | -7.35 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | -4.39 Million | -19.59 Million | -18.58 Million | - | - | - |
| Sales/Maturities of investments | - | - | - | 11.02 Million | 49.66 Million | 97.86 Million |
| Other Investing Activities | 19.92 Million | -5.58 Million | -13.68 Million | 14.56 Million | 53.39 Million | 101.28 Million |
| Financing Cash Flow | 15.73 Million | 102.77 Million | 26.38 Million | -47.89 Million | 9.95 Million | 141.43 Million |
| Debt repayment | -53.28 Million | -102.77 Million | -26.38 Million | -47.89 Million | -9.95 Million | -141.43 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.73 Million | 71.42 Million | 2.5 Million | -75.61 Million | -17.83 Million | 117.32 Million |
| Accounts receivables | 9000.00 | -786 Thousand | 532 Thousand | 302 Thousand | 427 Thousand | -424 Thousand |
| Accounts payables | -3000.00 | -845 Thousand | -3.04 Million | 3.89 Million | 32 Thousand | -48 Thousand |
| Inventory | 5.45 Million | - | - | - | - | -197 Million |
| Other working capital | -2.32 Million | 37.95 Million | 73.09 Million | 93.64 Million | -65.79 Million | -30.65 Million |
| Cash at beginning of period | 343.11 Million | 85.81 Million | 33.42 Million | 2.73 Million | 9.59 Million | 3.82 Million |
| Cash at end of period | 465.68 Million | 14.38 Million | 85.81 Million | 33.42 Million | 2.73 Million | 9.59 Million |
| Capital Expenditure | -1.17 Million | -1.99 Million | -46 Thousand | -66 Thousand | -1.74 Million | -7.35 Million |
| Effect of forex changes on cash | - | - | 2000.00 | -1000.00 | -999.00 | 55.52 Million |
| Net cash flow / Change in cash | 122.57 Million | -71.43 Million | 52.39 Million | 30.68 Million | -6.86 Million | 5.77 Million |
| Free Cash Flow | 86.92 Million | 51.18 Million | 75.24 Million | 104.31 Million | -66.48 Million | -233.52 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 64.55 Million | 18.58 Million | 18.58 Million | 27.38 Million | 13.69 Million | 14.87 Million |
| Depreciation & Amortization | 850 Thousand | 224 Thousand | 224 Thousand | 402 Thousand | 201 Thousand | 734 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.13 Million | 1.44 Million | 1.44 Million | 385 Thousand | 128.5 Thousand | 36.32 Million |
| Other non-cash items | 2.55 Million | 14.02 Million | 14.02 Million | -16.14 Million | -4.25 Million | 4.34 Million |
| Investing Cash Flow | -5.56 Million | 15.37 Million | 15.37 Million | -22.44 Million | -5.99 Million | -21.58 Million |
| Investments in PPE | -1.17 Million | - | - | -1.17 Million | -586 Thousand | -1.99 Million |
| Acquisitions | - | - | - | 5.41 Million | - | - |
| Investment purchases | -4.39 Million | 41.6 Million | - | -46 Million | - | -19.59 Million |
| Sales/Maturities of investments | - | - | - | 24.73 Million | - | - |
| Other Investing Activities | 19.92 Million | 15.37 Million | 15.37 Million | -5.41 Million | -5.41 Million | -5.58 Million |
| Financing Cash Flow | 53.28 Million | 8.79 Million | 8.79 Million | 16.62 Million | -925.5 Thousand | 102.77 Million |
| Debt repayment | -53.28 Million | -16.62 Million | - | -16.62 Million | - | -102.77 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 15.73 Million | 8.79 Million | 8.79 Million | -925.5 Thousand | -925.5 Thousand | 71.42 Million |
| Accounts receivables | 9000.00 | -73.5 Thousand | -73.5 Thousand | 156 Thousand | 78 Thousand | -786 Thousand |
| Accounts payables | -3000.00 | -131 Thousand | - | 128 Thousand | - | -845 Thousand |
| Inventory | 5.45 Million | 2.72 Million | 2.72 Million | - | - | - |
| Other working capital | -2.32 Million | -1.21 Million | -1.21 Million | 101 Thousand | 50.5 Thousand | 37.95 Million |
| Cash at beginning of period | 14.38 Million | 20.07 Million | - | 14.38 Million | - | 85.81 Million |
| Cash at end of period | 88.7 Million | 88.7 Million | 58.44 Million | 20.07 Million | 2.84 Million | 14.38 Million |
| Capital Expenditure | -1.17 Million | - | - | -1.17 Million | -586 Thousand | -1.99 Million |
| Effect of forex changes on cash | - | - | - | -1.00 | - | - |
| Net cash flow / Change in cash | 74.32 Million | 68.63 Million | 58.44 Million | 5.68 Million | 2.84 Million | -71.43 Million |
| Free Cash Flow | 73.68 Million | 34.27 Million | 34.27 Million | 10.33 Million | 9.18 Million | 51.18 Million |
ROSELABS
PNNEF
TMPL
UNICHEMLAB
601012
MSEXP